Ipsen Buying Memo Therapeutics For Up To $800M
By Al Barbarino · July 1, 2026, 4:06 PM EDT
French drugmaker Ipsen said Wednesday it has agreed to acquire Swiss biotechnology company Memo Therapeutics AG in a deal that could be worth more than €700 million ($796.6 million), expanding its...
To view the full article, register now.